
Please try another search
On the 23rd of March, Orbimed Advisors bought 750 thousand X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) shares for $7 million at an average price of $9.31 per share. Shares of X4 Pharmaceuticals, Inc. are down -1.61% since the transaction.
Orbimed Advisors's holding in X4 Pharmaceuticals, Inc. increased to about 1.8 million shares with the purchase.
Orbimed Advisors first bought X4 Pharmaceuticals, Inc. stock in the first quarter of 2019.
Other investors who also added to their X4 Pharmaceuticals, Inc. shares include Citigroup (NYSE:C) and Squarepoint Ops.
By Lewis Krauskopf NEW YORK (Reuters) - U.S. technology and growth stocks have taken the market's reins in recent weeks, pausing a rotation into value shares as investors assess...
(Reuters) - Cathie Wood’s ARK funds bought more shares of cryptocurrency exchange Coinbase Global Inc on Friday while selling shares of electric carmaker Tesla (NASDAQ:TSLA),...
(Reuters) - Insurer Hartford Financial Services Group (NYSE:HIG) said on Friday it had agreed to a settlement with the Boy Scouts of America and would pay $650 million for sexual...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.